2025年国家医保药品目录调整工作日前启动。今年目录调整中增设了商保创新药目录，这也是国家医保局将首次制定商业健康保险创新药品目录。 首版商保创新药目录 通过初审名单公布 昨天，国家医保局公示了通过2025年国家基本医疗保险、生育保险和工伤保险药品目录及商保创新药目录调整初步形式审查的药品及相关信息。 国家医保局共收到商保创新药目录申报信息141份，涉及药品通用名141个，经初步审核，121个药品通用名通过形式审查。其中，5款细胞疗法高值创新药进 入商保创新药目录。 形式审查是目录调整程序中的第一步，代表该药品具备了参与目录调整后续工作流程的资格，不代表其已经纳入了目录。 满足多元用药需求 助商业健康保险发展 基本医保和商业健康保险都是我国多层次医疗保障体系的重要组成部分。2024年，基本医保参保13.26亿人，参保率巩固在95%。当年基金总支出达到2.97万 亿元，为广大人民群众看病就医提供了坚实保障。 但基本医保总体筹资水平不高，人均筹资仅1070元，其中约2/3还是来自各级财政补助，因此必须牢牢把握"保基本"定位。 随着医药技术创新发展和医疗服务水平提升，确有一小部分临床效果显著、创新程度高的药品因超出 ...

Group 1 - The central government is set to establish a commercial health insurance innovative drug catalog to better meet the multi-level medication guarantee needs of the public [1] - The Ministry of Industry and Information Technology and the Ministry of Civil Affairs are promoting the design and development of intelligent elderly care service robots, with a pilot period from 2025 to 2027 [3] - The Ministry of Housing and Urban-Rural Development aims to achieve an average resource utilization rate of over 50% for construction waste in cities at the prefecture level and above by 2027 [6] Group 2 - The Beijing Municipal Bureau of Commerce is planning to create a global first-release center to support the renovation and upgrading of commercial districts and shopping malls [8] - The State Administration for Market Regulation has issued compliance guidelines for the "6·18" online promotional event, emphasizing fair market competition and the prevention of illegal activities [10] - Guiyang is establishing a joint meeting system to promote the development of the sports industry, with plans to introduce supportive policies and funding for sports products and services [11]